About this event
Tuesday March 23rd, 2021 - 3pm GMT / 4pm CET / 11am EDT
Duration: 30 minutes
Lyme disease (LD) is a tick-borne multisystem disorder caused by certain species of spirochetes from the Borrelia burgdorferi sensu lato complex, that are transmitted to a human via a tick bite.
Multiple frontline antibiotics used today to cure early LD, are triggering the transformation of the spiral form of Borrelia into a variety of persisting forms.
The signals that the spirochete receives from hostile environments provokes morphological alterations that keep the pathogen alive and prevent it from being cleared by antibodies – leading to recurring and chronic cases of LD.
Hear from Dr Natasha Rudenko (Deputy Head of the Laboratory of Molecular Ecology of Vectors and Pathogens, Institute of Parasitology, Biology Centre CAS) on how the identification of a new form of Borrelia led to the discovery of chronic Lyme Disease – and how this altered form may provide targets for new drugs and diagnostic tests.
This webinar has been made possible with the kind support of our partner, Thermo Fisher Scientific.
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events, reports, webinars and digital events, as well as operating a content-rich website.
Share this event